Adage Capital Partners
GPCR icon

Adage Capital Partners’s Structure Therapeutics GPCR Stock Holding History

Adage Capital Partners’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03M Buy
+75,000
New +$3.32M 0.01% 829
2024
Q4 		– Sell
-250,000
Closed -$11M – 909
2024
Q3 		$11M Sell
250,000
-963,099
-79% -$37.2M 0.02% 590
2024
Q2 		$47.6M Buy
1,213,099
+402,497
+50% +$16.5M 0.09% 226
2024
Q1 		$34.7M Sell
810,602
-946,316
-54% -$39.9M 0.07% 315
2023
Q4 		$71.6M Sell
1,756,918
-43,005
-2% -$2.46M 0.15% 150
2023
Q3 		$90.8M Buy
1,799,923
+1,607,525
+836% +$51.8M 0.21% 117
2023
Q2 		$8M Sell
192,398
-100,000
-34% -$2.8M 0.02% 605
2023
Q1 		$6.96M Buy
+292,398
New +$6.87M 0.02% 672

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Adage Capital Partners's GPCR Position: Q2 2026 in Review

Adage Capital Partners opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 75,000 shares worth $4.03M. The stake represents 0.01% of the portfolio and ranks #829 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in GPCR as recently as Q3 2024.

Adage Capital Partners first reported a position in GPCR in Q1 2023 and has held it in 8 quarters since. The position peaked at $90.8M in Q3 2023. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Adage Capital Partners held 75,000 shares of Structure Therapeutics worth $4.03M as of Q2 2026.
  • Structure Therapeutics was a new Adage Capital Partners position in Q2 2026.
  • Structure Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q2 2026, its #829 holding.
  • Adage Capital Partners first reported a position in Structure Therapeutics in Q1 2023 and has held it in 8 quarters since.
  • Adage Capital Partners's Structure Therapeutics position peaked at $90.8M in Q3 2023.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.